Cite
Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation Inhibitors
MLA
Lokesh Narsineni, et al. “Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation Inhibitors.” Molecular Pharmaceutics, vol. 19, no. 8, July 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ce1bc462928806014307da5c5036ea30&authtype=sso&custid=ns315887.
APA
Lokesh Narsineni, Praveen P. N. Rao, Amy Trinh Pham, & Marianna Foldvari. (2022). Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation Inhibitors. Molecular Pharmaceutics, 19(8).
Chicago
Lokesh Narsineni, Praveen P. N. Rao, Amy Trinh Pham, and Marianna Foldvari. 2022. “Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation Inhibitors.” Molecular Pharmaceutics 19 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ce1bc462928806014307da5c5036ea30&authtype=sso&custid=ns315887.